Xtent Overview
XTENT, Inc. develops customizable drug-eluting stent (DES) systems for the treatment of coronary artery disease. XTENT's customizable DES systems are designed to enable the treatment of single lesions, long lesions and multiple lesions of varying lengths and diameters, in one or more arteries with a single device.
(NASDAQ: XTNT)
Key People
Management
Board of Directors
Funding
| Date | Type | Capital Amount | Post-Money Valuation | Investors |
|---|---|---|---|---|
| 05/11/2006 | Series D | 30M | Unknown |
Products
| Name: | Xtent Custom NX Des Systems |
| Product URL: | http://www.xtentinc.com/solutions/products/ |
| Description: | XTENT's Custom NX 36 and Custom NX 60 DES Systems are designed to enable physicians to treat single, multiple or long lesions by customizing the length of stent placed at the treatment site. The Custom NX 36 system consists of six 6mm drug eluting stent segments, which allows the placement of up to 36mm of stent. The Custom NX 60 system consists of ten 6mm drug eluting stent segments, which allows the placement of up to 60mm of stent. The length of the balloon within the system is also customizable, allowing for post-dilatation following stent deployment. |
Competitors
No competitors have been recorded yet. Add a competitor.
Related Companies
User Opinions
Bulls vs. Bears (0)
| Bullish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to succeed | ||||
| Bearish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to stumble. | ||||
Discussions (0)
Start a New Discussion
Opinion Poll
View All Opinions »Web Metrics
View All Web Metrics »Discussions
View All Discussions »There are no discussions right now.
Recent Contributors
There are no recent contributors to this company.

loading...
Profile
Opinions
